Clinical Trials Directory

Trials / Completed

CompletedNCT00436137

Improving Followup of Abnormal Colon Cancer Screening Tests

Improving Followup of Positive Fecal Occult Blood Tests

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Harvard Vanguard Medical Associates · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether direct mailings to patients with positive fecal occult blood tests can increase rates of performing followup colonoscopy.

Detailed description

Screening programs using the fecal occult blood test (FOBT) have demonstrated a significant reduction in colorectal cancer mortality, although only when accompanied by a complete diagnostic evaluation of the colon in the setting of a positive result. 90% of patients with a positive FOBT result have completed a subsequent colonoscopy within Harvard Vanguard Medical Associates. This project will use a pre-post study design to increase the rate of followup colonoscopy in the setting of positive FOBT results. Patients in the intervention group will receive a personalized mailing highlighting their positive result and need for colonoscopy, followed by telephone outreach from a centralized gastroenterology scheduling office. The primary outcome will be the performance of colonoscopy, however we will also perform chart reviews to identify predictors of completing appropriate followup.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPatient mailingPatient will receive a mailing recommending colonoscopy, followed by telephone outreach

Timeline

Start date
2007-06-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-02-16
Last updated
2008-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00436137. Inclusion in this directory is not an endorsement.